ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
Conditions: Obesity; Liver Diseases; Liver Fibrosis; Liver Fat; NAFLD; Weight Loss; Insulin Resistance; Insulin Sensitivity; Insulin Sensitivity/Resistance; Metabolic Diseases; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus; NASH With Fibrosis; Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non-alcoholic Steatohepatitis Interventions: Device: ESG; Drug: GLP1-RA Sponsors: Pichamol Jirapinyo, MD, MPH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Aerobic Exercise on Fitness Score and Blood Glucose Level in Adolescents Girls With Diabetes Mellitus
Conditions: Type 1 Diabetes Mellitus Interventions: Other: aerobic exercise Sponsors: MTI University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
The Impact of Vitamin D Supplementation on Pregnant Women With the Risk of GDM
Conditions: Gestational Diabetes Mellitus Interventions: Drug: Placebo supplementation; Drug: Vitamin D supplementation Sponsors: IIMC, Riphah International University, Pakistan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
HomeStyles-Adults of Chinese Heritage
Conditions: Healthy Lifestyle; Home Environment Related Disease; Cardiometabolic Disease; Systemic Inflammatory Response; Health Behavior; Dietary Habits; Physical Inactivity; Self Efficacy; Gut Microbiota; Diabetes Mellitus Interventions: Behavioral: HomeStyles-China Sponsors: Rutgers, The State University of New Jersey; National Institute on Minority Health and Health Disparities (NIMHD) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Assessment of Gastric Emptying by SHR20004 in Healthy Subjects
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: Acetaminophen/SHR20004; Drug: Acetaminophen/Placebo Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
TeleCare North Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Telemonitoring 1; Other: Telemonitoring 2 Sponsors: Aalborg University Hospital; Steno Diabetes Center Nordjylland; Aalborg University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk
Conditions: Diabetes Mellitus, Type 2 Interventions: Behavioral: HIIT Sponsors: Faculdade de Motricidade Humana; Funda ção para a Ciência e a Tecnologia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Chemerin, Fetuin-A, IL-34 and IL-13 Levels in Diabetic Periodontitis Patients
Conditions: Periodontitis; Diabetes Mellitus, Type 2 Interventions: Procedure: Non-Surgical Periodontal Treatment Sponsors: Marmara University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Conditions: Healthy; Type 2 Diabetes Mellitus Interventions: Drug: LY3938577; Drug: Placebo; Drug: Insulin degludec Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Impact GLP-1 Agonists Following Bariatric
Conditions: Morbid Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Obstructive Sleep Apnea of Adult Interventions: Drug: GLP-1 receptor agonist Sponsors: University of Missouri-Columbia; American Society for Metabolic and Bariatric Surgery Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Health promotion; Other: Usual care Sponsors: Azienda Ospedaliero-Universitaria Careggi; Azienda Ospedaliera Universitaria Renato Dulbecco; AUSL - IRCCS in Tecnologie Avanzate e Modelli Assistenziali in Oncologia di Reggio Emilia; Istituto Nazionale per la promozione della salute delle popolazioni Migranti e per il contrasto delle malattie della Povert à (INMP) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes
Conditions: Diabetes Type 2; Hypertriglyceridemia; Diabetes Mellitus Interventions: Dietary Supplement: EPAVasc; Dietary Supplement: Corn Oil Sponsors: University of Ioannina; LIBYTEC Pharmaceutical S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1; Systolic Dysfunction; Diastolic Dysfunction Interventions: Diagnostic Test: transthoracic echocardiography Sponsors: Sirnak State Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation
Conditions: Gestational Diabetes Interventions: Drug: 500 mg of ursodeoxycholic acid (UDCA); Other: 500 mg of Placebo Sponsors: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
Conditions: Bioequivalence; Diabetes Mellitus, Type 2 Interventions: Drug: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet Sponsors: Galenicum Health Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
